Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion type Assertion NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_head.
- NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion wasGeneratedBy ECO_0000203 NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_provenance.
- NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion wasDerivedFrom befree-2016 NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_provenance.
- NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion SIO_000772 18054208 NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_provenance.
- NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion evidence source_evidence_literature NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_provenance.
- NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_assertion description "[In a previous study we found platelet expression reduction of the 18 kDa Translocator Protein (TSPO) (the new nomenclature for the peripheral-type benzodiazepine receptor) in patients with panic disorder who also fulfilled the diagnostic criteria for ASAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642933.RAyMG6zwt0N10L86ETD-JlfW45hsrmnMg17PwwVM3pZ24130_provenance.